GARDASIL - 0006-4109-09 - (Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant)

Alphabetical Index


Drug Information of GARDASIL

Product NDC: 0006-4109
Proprietary Name: GARDASIL
Non Proprietary Name: Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant
Active Ingredient(s): 40; 40; 20; 20    ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL & nbsp;   Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant
Administration Route(s): INTRAMUSCULAR
Dosage Form(s): INJECTION, SUSPENSION
Coding System: National Drug Codes(NDC)

Labeler Information of GARDASIL

Product NDC: 0006-4109
Labeler Name: Merck Sharp & Dohme Corp.
Product Type: VACCINE
FDA Application Number: BLA125126
Marketing Category: BLA
Start Marketing Date: 20060608

Package Information of GARDASIL

Package NDC: 0006-4109-09
Package Description: 6 SYRINGE in 1 CARTON (0006-4109-09) > .5 mL in 1 SYRINGE (0006-4109-01)

NDC Information of GARDASIL

NDC Code 0006-4109-09
Proprietary Name GARDASIL
Package Description 6 SYRINGE in 1 CARTON (0006-4109-09) > .5 mL in 1 SYRINGE (0006-4109-01)
Product NDC 0006-4109
Product Type Name VACCINE
Non Proprietary Name Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant
Dosage Form Name INJECTION, SUSPENSION
Route Name INTRAMUSCULAR
Start Marketing Date 20060608
Marketing Category Name BLA
Labeler Name Merck Sharp & Dohme Corp.
Substance Name HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN
Strength Number 40; 40; 20; 20
Strength Unit ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL
Pharmaceutical Classes Inactivated Human Papillomavirus Vaccine [EPC],Actively Acquired Immunity [PE],Papillomavirus Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Human Papillomavirus Vaccine [EPC],Actively Acquired Immunity [PE],Papillomavirus Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Human Papillomavirus Vaccine [EPC],Actively Acquired Immunity [PE],Papillomavirus Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Human Papillomavirus Vaccine [EPC],Actively Acquired Immunity [PE],Papillomavirus Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient]

Complete Information of GARDASIL


General Information